BioNTech CEO Sahin reports 63,209-share sale
BioNTech CEO Ugur Sahin reported selling 63,209 shares of BioNTech SE at $94.07 apiece in a Form 4 filing. The filing says the transaction was made under a 10b5-1 plan.
BioNTech CEO Ugur Sahin reported selling 63,209 shares of BioNTech SE at $94.07 apiece in a Form 4 filing. The filing says the transaction was made under a 10b5-1 plan.